Inventor · disambiguated record
Markus Riederer
Also filed as: RIEDERER MARKUS
5 granted patents·2 pending applications·16 citations·filing 2004–2018
72Inventor score
Files withACTELION PHARMACEUTICALS LTD3ACTELION PHARMACEUTICAL LTD2FRETZ HEINZ1IDORSIA PHARMACEUTICALS LTD1
Top patents by PatentIndex Score
7 records- 0183US7714132B2Tetrahydropyridoindole derivativesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted May 11, 2010·7 cites·25 claims
- 0278US7897788B2Indol-1-yl-acetic acid derivativesACTELION PHARMACEUTICAL LTD·Filed 2005·Granted Mar 1, 2011·5 cites·13 claims
- 0376US8039474B22,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonistsACTELION PHARMACEUTICAL LTD·Filed 2005·Granted Oct 18, 2011·4 cites·14 claims
- 0451US2007037846A1Pyrazolidinedione derivativesACTELION PHARMACEUTICALS LTD·Filed 2004·Application pending·0 cites
- 0541US2010234396A1Tetrhydropyridoindole DerivativesACTELION PHARMACEUTICALS LTD·Filed 2010·Application pending·0 cites
- 0639US11179390B2Subcutaneous administration of a P2Y12 receptor antagonistIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Nov 23, 2021·0 cites·50 claims
- 0738US8273740B22-sulfanyl-benzoimidazol-1-yi-acetic acid derivatives as CRTH2 antagonistsFRETZ HEINZ·Filed 2005·Granted Sep 25, 2012·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Markus Riederer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →